Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates

Overview of attention for article published in Nature Communications, May 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

news: 2 news outlets
twitter: 13 X users

facebook: 3 Facebook pages

Citations

dimensions_citation: 110 Dimensions

Readers on

mendeley: 165 Mendeley

Summary News X Facebook Dimensions citations

So far, Dimensions has found 110 publications that cite this research output.

110

The most recent citing publications are shown below. View all 110 publications that cite this research output on Dimensions.

Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study

Article in Leukemia & Lymphoma (March 2024)

Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma

Preprint in Research Square (February 2024)

Modern approaches to assessment of minimal residual disease in multiple myeloma (plasma cell myeloma) cases

Article in Medicine of Extreme Situations (December 2023)